raloxifene hydrochloride has been researched along with Alloxan Diabetes in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azizian, H; Ebrahimi, MN; Karam, GA; Khaksari, M; Raji-Amirhasani, A; Sepehri, G | 1 |
| Cho, DC; Gupta, R; Han, I; Kim, CH; Kim, KT; Kwon, JT; Lee, YS; Park, EK; Seo, YJ; Seu, SY; Sung, JK | 1 |
| Brown, DM; Burr, DB; Gallant, MA; Hill Gallant, KM; Sato, AY; Williams, JN | 1 |
| Mirsky, N; Shen, M; Somjen, D; Stern, N | 1 |
4 other study(ies) available for raloxifene hydrochloride and Alloxan Diabetes
| Article | Year |
|---|---|
The effects of alone and combination tamoxifen, raloxifene and estrogen on lipid profile and atherogenic index of ovariectomized type 2 diabetic rats.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Drug Therapy, Combination; Estrogens; Female; Lipids; Menopause; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Streptozocin; Tamoxifen | 2020 |
Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.
Topics: Alendronate; Animals; Biomarkers; Bone Density; Bone Remodeling; Collagen Type I; Diabetes Mellitus, Experimental; Diphosphonates; Disease Models, Animal; Female; Humans; Lumbar Vertebrae; Osteocalcin; Osteoporosis, Postmenopausal; Ovariectomy; Peptides; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Streptozocin; X-Ray Microtomography | 2018 |
Raloxifene prevents skeletal fragility in adult female Zucker Diabetic Sprague-Dawley rats.
Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Remodeling; Diabetes Mellitus, Experimental; Female; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Rats, Zucker | 2014 |
Diabetes modulates differentially creatine kinase-specific activity responsiveness to estradiol-17beta and to raloxifene in rat organs.
Topics: Animals; Bone and Bones; Cardiovascular System; Creatine Kinase; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Estradiol; Female; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Uterus | 2006 |